Changeflow GovPing Pharma & Drug Safety Incyte patents fused pyrimidines, A2A/A2B inhib...
Routine Notice Added

Incyte patents fused pyrimidines, A2A/A2B inhibitors, EP3810610A1

Email

Summary

Incyte patents fused pyrimidines, A2A/A2B inhibitors, EP3810610A1

Source document (simplified)

← EPO Patent Bulletin

FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS

Publication EP3810610A1 Kind: A1 Mar 25, 2026

Applicants

Incyte Corporation

Inventors

MCCAMMANT, Matthew S., ZHAO, Le, WANG, Xiaozhao, HAN, Heeoon, WU, Liangxing, YAO, Wenqing, YU, Zhiyong

IPC Classifications

C07D 487/04 20060101AFI20191122BHEP A61P 9/00 20060101ALI20191122BHEP A61P 25/28 20060101ALI20191122BHEP A61P 29/00 20060101ALI20191122BHEP A61P 35/00 20060101ALI20191122BHEP C07D 519/00 20060101ALI20191122BHEP A61K 31/519 20060101ALI20191122BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.